Sjöcasing Sjögren’s: An Exhibit of Heterogeneous Disease, Unpredictable Progression, and Evolving Manifestations

Grand Horizon Ballroom EF , Marriott Marquis Chicago| Developed and offered by Novartis Pharmaceuticals Corporation.

Program Description

Sjögren’s disease is a systemic autoimmune disease that can be serious and progressive. In this combined presentation and exhibit, we will explore the heterogeneity of the disease, highlighting the potential for a wide range of organ involvement beyond sicca symptoms, specifically covering the glandular, articular, cutaneous, lymphadenopathy, and other organ domains. Sjögren’s is a constant presence causing daily challenges that impact quality of life. Despite the systemic impact, there are no FDA-approved therapies targeting the underlying pathogenesis or slowing disease progression. The application of the “sicca plus” framework in clinical practice can aid in identifying patients who may benefit from biologic therapy.